News Releases 2016

RSS

21 DEC 2016 Nutraceuticals
Otsuka Pharmaceutical Enters into Health Promotion Partnership with Gunma Prefecture
20 DEC 2016 Pharmaceuticals
Akebia Therapeutics and Otsuka Pharmaceutical Announce Collaboration to Develop and Commercialize Vadadustat in the U.S.
20 DEC 2016 Nutraceuticals
JSC High Performance Center Total Conditioning Research Project
Joint research aims to promote sports medicine and science and boost international competitiveness
15 DEC 2016 Pharmaceuticals
Otsuka Signs Japan-Exclusive License Agreement with
Takara Bio for the Investigational Cancer Treatment HF10, an Oncolytic Virus
5 DEC 2016 Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Cooperative Partnership with Nara Prefecture
1 DEC 2016 Pharmaceuticals
FDA Accepts For Review A Supplemental New Drug Application To Expand Labeling Of Abilify Maintena® (aripiprazole) For The Treatment Of Bipolar I Disorder
25 NOV 2016 Corporate
Otsuka Joins UN Global Compact
24 NOV 2016 Nutraceuticals
Otsuka Pharmaceutical Enters into Cooperative Agreements with Hokkaido Government Entities
- Partnership Agreement for Promotion of Hokkaido Residents’ Health Initiatives -
- Cooperative Accord for Children’s Education and Sports Promotion -
21 NOV 2016 Corporate
Otsuka Pharmaceutical Cooperates with Community Health Promotion Efforts
Tokushima Itano Factory Sponsors Asan Walking Festival in Itano

Go to the Top

18 NOV 2016 Pharmaceuticals
ICLUSIG® Tablets 15 mg Now Available in Japan for Patients with Chronic Myeloid Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
18 NOV 2016 Pharmaceuticals
New 1 mg Tablet Dosage of Antipsychotic ABILIFY
Available in Japan
10 NOV 2016 Nutraceuticals
Relationship between PMS/PMDD and production status of soy isoflavone metabolite equol
Presentation to the Japan Society for Menopause and Women’s Health
1 NOV 2016 Nutraceuticals
Otsuka Pharmaceutical Enters into Comprehensive Partnership
with Hyogo Prefecture
31 OCT 2016 Nutraceuticals
Heatstroke Prevention Communication Project Hitosuzumi Awards 2016
Otsuka Pharmaceutical Named “Best Communicator” for Third Consecutive Year Proactive Efforts to Raise Awareness Also Recognized with “Top Runner Award”
28 OCT 2016 Nutraceuticals
ORONAMIN C DRINK Recognized with
Good Design Long Life Design Award
28 OCT 2016 Nutraceuticals
POCARI SWEAT Recognized with
Good Design Long Life Design Award
19 OCT 2016 Pharmaceuticals
Positive Phase III Clinical Trial Results for Ribociclib (LEE011), an Investigational Compound for Advanced Breast Cancer in Development by Major Pharmaceutical Company under a Research Collaboration with Otsuka’s Subsidiary Astex Pharmaceuticals
18 OCT 2016 Nutraceuticals
Otsuka Pharmaceutical Enters into Disaster Support Agreement with Fukui Prefecture
28 SEP 2016 Pharmaceuticals
Otsuka Receives Approval in Japan for Mikeluna® Combination Ophthalmic Solution, a New Treatment for Glaucoma and Ocular Hypertension

Go to the Top

Go to the Top

Go to the Top

Go to the Top

Go to the Top

Go to the Top